Neuropsychiatric sequelae of stroke

被引:182
作者
Ferro, Jose M. [1 ]
Caeiro, Lara [2 ]
Figueira, Maria Luisa [1 ]
机构
[1] Univ Lisbon, Ctr Hosp Lisboa Norte, Dept Neurosci, Prof Egas Moniz Ave, P-1649035 Lisbon, Portugal
[2] Univ Lisbon, Inst Mol Med, Prof Egas Moniz Ave, P-1649028 Lisbon, Portugal
关键词
POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; TRANSIENT ISCHEMIC ATTACK; SMALL-VESSEL DISEASE; POSTSTROKE DEPRESSION; CEREBRAL MICROBLEEDS; NATURAL-HISTORY; LESION LOCATION; FUNCTIONAL RECOVERY; PERSONALITY-TRAITS;
D O I
10.1038/nrneurol.2016.46
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Stroke survivors are often affected by psychological distress and neuropsychiatric disturbances. About one-third of stroke survivors experience depression, anxiety or apathy, which are the most common neuropsychiatric sequelae of stroke. Neuropsychiatric sequelae are disabling, and can have a negative influence on recovery, reduce quality of life and lead to exhaustion of the caregiver. Despite the availability of screening instruments and effective treatments, neuropsychiatric disturbances attributed to stroke are currently underdiagnosed and undertreated. Stroke severity, stroke-related disabilities, cerebral small vessel disease, previous psychiatric disease, poor coping strategies and unfavourable psychosocial environment influence the presence and severity of the psychiatric sequelae of stroke. Although consistent associations between psychiatric disturbances and specific stroke locations have yet to be confirmed, functional MRI studies are beginning to unveil the anatomical networks that are disrupted in stroke-associated psychiatric disorders. Evidence regarding biochemical and genetic biomarkers for stroke-associated psychiatric disorders is still limited, and better understanding of the biological determinants and pathophysiology of these disorders is needed. Investigation into the management of these conditions must be continued, and should include pilot studies to assess the benefits of innovative behavioural interventions and large-scale cooperative randomized controlled pharmacological trials of drugs that are safe to use in patients with stroke.
引用
收藏
页码:269 / U48
页数:13
相关论文
共 156 条
[1]
Personality Type as a Predictor for Depressive Symptoms and Reduction in Quality of Life Among Stroke Survivals [J].
Afanasiev, Svetlana ;
Aharon-Peretz, Judith ;
Granot, Michal .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2013, 21 (09) :832-839
[2]
B-Vitamins Reduce the Long-Term Risk of Depression After Stroke: The VITATOPS-DEP Trial [J].
Almeida, Osvaldo P. ;
Marsh, Kylie ;
Alfonso, Helman ;
Flicker, Leon ;
Davis, Timothy M. E. ;
Hankey, Graeme J. .
ANNALS OF NEUROLOGY, 2010, 68 (04) :503-510
[3]
Development of neuropsychiatric symptoms in poststroke patients: a cross-sectional study [J].
Angelelli, P ;
Paolucci, S ;
Bivona, U ;
Piccardi, L ;
Ciurli, P ;
Cantagallo, A ;
Antonucci, G ;
Fasotti, L ;
Di Santantonio, A ;
Grasso, MG ;
Pizzamiglio, L .
ACTA PSYCHIATRICA SCANDINAVICA, 2004, 110 (01) :55-63
[4]
[Anonymous], 2013, PREVALENCE FAECAL
[5]
[Anonymous], 2004, Assessing psychological trauma and PTSD
[6]
[Anonymous], NEUROPSYCHIATRIC SYM
[7]
[Anonymous], 2013, NEUROPSYCHIATRIC SYM
[8]
[Anonymous], COCHRANE DATABASE SY
[9]
[Anonymous], GEN HOSP PSYCHIAT
[10]
[Anonymous], BMJ CASE REP